Preferred Label : treprostinil;

CISMeF synonym : UT-15; UT15 compound; remodulin; Orenitram;

MeSH synonym : ((1R,2R,3AS,9AS)-2-hydroxy-1-((3S)-3-hydroxyoctyl)-2,3,3A,4,9,9A-hexahydro-1H-cylopent(b)naphthalen-5-yl)oxy)acetate;

MeSH hyponym : trepostinil sodium; treprostinil diolamin; treprostinil diethanolamine;

MeSH Related Number : treprostinil sodium; 7JZ75N2NT6; H1FKG90039;

Related CAS MeSH : 7JZ75N2NT6 (treprostinil sodium);

Is substance : O;

UNII : RUM6K67ESG;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-marr/treprostinil
2023
false
false
false
France
French
risk management
Catheter related bloodstream infection (disorder)
guidelines for drug use
treprostinil
patient education handout
infusions, intravenous
Infusion Pumps

---
https://www.ema.europa.eu/en/medicines/human/EPAR/trepulmix
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treprostinil
treprostinil
treprostinil
Chronic thromboembolic pulmonary hypertension
chronic disease
orphan drug production
hypertension, pulmonary
pulmonary thromboembolisms
infusions, intravenous
drug interactions
pregnancy
breast feeding
vasodilator agents
vasodilator agents
adult
aged
drug evaluation, preclinical
pulmonary embolism
epoprostenol
epoprostenol
epoprostenol

---
https://www.has-sante.fr/portail/jcms/c_2893495/fr/treprostinil-reddy-pharma?xtmc=&xtcr=30
2019
false
false
false
France
French
treatment outcome
treprostinil
evaluation of the transparency committee
epoprostenol
epoprostenol

---
http://www.has-sante.fr/portail/jcms/c_1738594/fr/remodulin
2014
false
France
French
evaluation of the transparency committee
treprostinil sodium
treprostinil
treprostinil
treprostinil sodium
treprostinil
infusions, intravenous
treatment outcome
insurance, health, reimbursement
hypertension, pulmonary
epoprostenol

---
http://www.has-sante.fr/portail/jcms/c_1738594/fr/remodulin-iv-treprostinil-prostacycline
2014
false
false
false
France
French
treprostinil sodium
epoprostenol
treprostinil
infusions, intravenous
treprostinil
hypertension, pulmonary
treatment outcome
randomized controlled trials as topic
treprostinil sodium
treprostinil
evaluation of the transparency committee
guidelines for drug use

---
http://www.has-sante.fr/portail/jcms/c_1024124/remodulin
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-02/remodulin_-_ct-_6327.pdf
2011
France
French
antihypertensive agents
treprostinil
epoprostenol
hypertension, pulmonary
infusions, subcutaneous
treatment outcome
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-05/synthese_davis_reevaluation_htap_2011-05-12_12-18-35_386.pdf
http://www.has-sante.fr/portail/jcms/c_1053751/medicaments-de-lhypertension-arterielle-pulmonaire-idiopathique-ou-associee-a-une-connectivite
2011
false
France
French
evaluation of the transparency committee
guidelines for drug use
Sildenafil Citrate
Tadalafil
hypertension, pulmonary
collagen diseases
epoprostenol
antihypertensive agents
sulfonamides
treprostinil
epoprostenol
phosphodiesterase 5 inhibitors
iloprost
receptors, endothelin
ambrisentan
phenylpropionates
DERMATITIS
survival analysis
Antihypertensives for pulmonary arterial hypertension
treatment outcome
pyridazines
Bosentan

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Remodulin_Resubmission-Fr.pdf
2006
Canada
French
hypertension, pulmonary
epoprostenol
antihypertensive agents
treprostinil
injections, subcutaneous
treatment outcome
insurance, health, reimbursement
canada
treprostinil
drug evaluation

---
https://www.cadth.ca/sites/default/files/pdf/108_No31_treprostinil_edrug_f.pdf
2002
Canada
French
epoprostenol
hypertension, pulmonary
epoprostenol
treatment outcome
treprostinil
treprostinil
drug evaluation

---
Nous contacter.
19/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.